Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Heshu Liu
Observed name:
Liu, Heshu
Institutions:
Beijing Tongren Hospital,
Capital Medical University
Observed institutions:
Beijing Tongren Hospital,
Capital Medical University,
Beijing Chao-Yang Hospital, Capital Medical University
ORCID:
0000-0003-4999-8484
Observed ORCID:
0000-0003-4999-8484
OpenAlex ID:
A5081203128
Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer
2021
·
Hang Zheng
, Heshu Liu
, et al.
·
Cancer Cell International
·
173
PDF
Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer
2022
·
Hang Zheng
, Heshu Liu
, et al.
·
Stem Cell Research & Therapy
·
157
PDF
Inhibition of DCLK1 sensitizes resistant lung adenocarcinomas to EGFR-TKI through suppression of Wnt/β-Catenin activity and cancer stemness
2022
·
Rui Yan
, Xiaona Fan
, et al.
·
Cancer Letters
·
87
Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer
2021
·
Hang Zheng
, Heshu Liu
, et al.
·
Frontiers in Molecular Biosciences
·
83
PDF
Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma
2021
·
Jiannan Yao
, Ling Duan
, et al.
·
Frontiers in Oncology
·
47
DCLK1 Plays a Metastatic-Promoting Role in Human Breast Cancer Cells
2019
·
Heshu Liu
, Tao Wen
, et al.
·
BioMed Research International
·
46
PDF
Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6/STAT3 signaling
2023
·
Heshu Liu
, Rui Yan
, et al.
·
Breast Cancer Research
·
37
PDF
ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation
2019
·
Qun Liu
, Heshu Liu
, et al.
·
International Journal of Oncology
·
35
PDF
Disruption of Core 1-mediated O-glycosylation oppositely regulates CD44 expression in human colon cancer cells and tumor-derived exosomes
2019
·
Tianbo Gao
, Tao Wen
, et al.
·
Biochemical and Biophysical Research Communications
·
34
Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma
2022
·
Yang Ge
, Heshu Liu
, et al.
·
Translational Oncology
·
30
PDF
Combination of anlotinib and gemcitabine promotes the G0/G1 cell cycle arrest and apoptosis of intrahepatic cholangiocarcinoma in vitro
2021
·
Shanshan Fan
, Yang Ge
, et al.
·
Journal of Clinical Laboratory Analysis
·
26
PDF
DCLK1 Suppresses Tumor-Specific Cytotoxic T Lymphocyte Function Through Recruitment of MDSCs via the CXCL1-CXCR2 Axis
2022
·
Rui Yan
, Jianjian Li
, et al.
·
Cellular and Molecular Gastroenterology and Hepatology
·
23
A targetable MYBL2-ATAD2 axis governs cell proliferation in ovarian cancer
2022
·
Qun Liu
, Heshu Liu
, et al.
·
Cancer Gene Therapy
·
18
Prognostic Significance and Therapeutic Potential of SERPINE1 in Head and Neck Squamous Cell Carcinoma
2025
·
Changyu Zhu
, Heshu Liu
, et al.
·
Cancer Medicine
·
12
PDF
DCLK1 Drives EGFR-TKI-Acquired Resistance in Lung Adenocarcinoma by Remodeling the Epithelial–Mesenchymal Transition Status
2023
·
Rui Yan
, Xuying Huang
, et al.
·
Biomedicines
·
11
PDF
Preventive Treatment with PD-1 Antibody Increases Tissue-resident Memory T Cells Infiltration and Delays Esophageal Carcinogenesis
2023
·
Zeru Xiao
, Rui Yan
, et al.
·
Cancer Prevention Research
·
10
Toxicity profiles of immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta‐analysis
2024
·
Shoutao Dang
, Xinyu Li
, et al.
·
Cancer Medicine
·
8
Hypoxic stimulation of DCLK1 transcription and alternative-promoter switching fuels tumor malignancy in clear cell renal cell carcinoma
2025
·
Jiannan Yao
, Xuying Huang
, et al.
·
Cell Death and Disease
·
2
PDF
Single-Cell Transcriptomic Analysis Identifies an Invasive Epithelial Subpopulation Associated with the TGFβ–SERPINE1 Axis in HNSCC
2026
·
Heshu Liu
, Yijun Shi
, et al.
·
Biomedicines
Longitudinal intratumoral and peritumoral MRI radiomics for predicting pathologic complete response to neoadjuvant chemoimmunotherapy in locally advanced head and neck squamous cell carcinoma: a retrospective two-center study
2026
·
Shitong Lou
, Ling Duan
, et al.
·
Research Square
PDF
Integrated single-cell and bulk transcriptomic analyses reveal a stem-like epithelial subpopulation in adenocarcinoma of the esophagogastric junction and identify VASN as a novel regulator of tumor stemness
2026
·
Hang Zheng
, Shuaibo Wang
, et al.
·
Frontiers in Immunology
Immunotherapy with Chemotherapy in Recurrent or Metastatic Maxillary Sinus Squamous Cell Carcinoma: A Real-world Study in China
2026
·
Shuyang Zhang
, Jingyang Zhao
, et al.
·
Current Cancer Drug Targets
Table S1 from DCLK1-Short Splice Variant Promotes Esophageal Squamous Cell Carcinoma Progression via the MAPK/ERK/MMP2 Pathway
2023
·
Yang Ge
, Xiaona Fan
, et al.
Supplementary Figure 2 from DCLK1-Short Splice Variant Promotes Esophageal Squamous Cell Carcinoma Progression via the MAPK/ERK/MMP2 Pathway
2023
·
Yang Ge
, Xiaona Fan
, et al.
Supplementary Figure 5 from DCLK1-Short Splice Variant Promotes Esophageal Squamous Cell Carcinoma Progression via the MAPK/ERK/MMP2 Pathway
2023
·
Yang Ge
, Xiaona Fan
, et al.
PDF
Show more works
View as search
Works count:
34
Citation count:
839
H-index:
13
I10-index:
16
Year
Topic
Type